FindTrial
Sign In

The Effects of Yoga in Prevention of Pregnancy Complications in pregnant women who have high chance of developing them.

The effect of yoga interventions in prevention of pregnancy complications in high risk pregnancies - A randomized controlled obstetric Doppler trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/10/002096
Enrollment
54
Registered
2011-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Preeclampsia, Eclampsia, IUGR, Fetal Death, PIH, Placental Abruption

Interventions

Intervention1: Yoga: Simple, stress-reducing practices from 13 weeks gestation to 28th week gestation (16 weeks). The practices included simple asanas, breathing exercises, visualization, guided image

Sponsors

AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women within 8 to 12 weeks of pregnancy and with any of the following risk factors were considered qualified for the study: Bad obstetrics history Twin pregnancies Maternal age between 14 and 20 or between 35 and 45 Obesity (BMI greater than 30) History of pregnancy complications among blood relatives: sister, mother, or grandmother

Exclusion criteria

Exclusion criteria: Qualified subjects with any of the following disorders were excluded from the study: Severe renal, hepatic or gallbladder, or heart disease. Structural abnormalities in the reproductive system. Hereditary anemia (such as sickle cell disease) or hemoglobin S-C disease, Seizure disorders. Taking chemotherapy drugs. Having sexually transmitted diseases including syphilis and HIV infection. Having any medical conditions that prevent them from safely and effectively practicing the interventions (e.g. spinal deformities or any DSM-IV type I axis psychiatric condition)

Design outcomes

Primary

MeasureTime frame
Maternal Blood Pressure Protein in urine, Platelet count, blood uric acid, Doppler parameters, stress instruments, and Blood markers: TNF-alpha;, IL-6, IL-10, sFlt-1, E-selectin, endoglin, and adiponectinTimepoint: 12th week, 20th week, and 28th week gestation;Maternal Blood Pressure Protein in urine, Platelet count, blood uric acid, Doppler parameters, stress instruments, and Blood markers: TNF-alpha;, IL-6, IL-10, sFlt-1, E-selectin, endoglin, and adiponectinTimepoint: 12th week, 20th week, and 28th week gestation—

Secondary

MeasureTime frame
Measure of stress: Objectively: Heart Rate Variability (HRV) and subjectively: Perceived Stress Scale (PSS)Timepoint: 13th week, 20th week, 28th week gestation—

Countries

India

Contacts

Public ContactAbbas Rakhshani

St John Medical College and Hospital

ritamhaskar@yahoo.com080-22065780

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026